×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PLSE – pulse biosciences, inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PLSE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/6
10:08 am
plse
Pulse Biosciences (NASDAQ:PLSE) was given a new $30.00 price target on by analysts at Mizuho.
High
Report
Pulse Biosciences (NASDAQ:PLSE) was given a new $30.00 price target on by analysts at Mizuho.
2/5
07:00 pm
plse
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
High
Report
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
2/4
04:05 pm
plse
Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
High
Report
Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
2/3
07:23 am
plse
Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium [Yahoo! Finance]
Low
Report
Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium [Yahoo! Finance]
2/3
07:00 am
plse
Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
Low
Report
Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
1/30
07:00 am
plse
Pulse Biosciences (NASDAQ:PLSE) is now covered by analysts at Mizuho. They set an "outperform" rating and a $25.00 price target on the stock.
Low
Report
Pulse Biosciences (NASDAQ:PLSE) is now covered by analysts at Mizuho. They set an "outperform" rating and a $25.00 price target on the stock.
1/12
05:45 am
plse
How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh [Yahoo! Finance]
Low
Report
How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh [Yahoo! Finance]
1/9
07:16 am
plse
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors [Yahoo! Finance]
Low
Report
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/9
04:30 pm
plse
Form 144 PULSE BIOSCIENCES, INC. Filed by: Danahy Kevin Patrick
Low
Report
Form 144 PULSE BIOSCIENCES, INC. Filed by: Danahy Kevin Patrick
2/6
09:21 pm
plse
Form 4 PULSE BIOSCIENCES, INC. For: Jan 08 Filed by: Sainz Maria
High
Report
Form 4 PULSE BIOSCIENCES, INC. For: Jan 08 Filed by: Sainz Maria
2/6
09:18 pm
plse
Form 3 PULSE BIOSCIENCES, INC. For: Jan 08 Filed by: Sainz Maria
High
Report
Form 3 PULSE BIOSCIENCES, INC. For: Jan 08 Filed by: Sainz Maria
2/6
06:02 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Feb 05
High
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Feb 05
1/14
09:00 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Jan 14
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Jan 14
1/9
09:12 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Jan 08
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Jan 08
12/18
09:00 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 18
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 18
12/12
04:04 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 09
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Dec 09
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results
33.7%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
TOP News Decliners
2/13
Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in Dermatology
-29.8%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: